Inovio Pharmaceuticals (INO) Earnings Date & Reports

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

INO is expected to report earnings to fall 14.75% to -23 cents per share on August 12

Inovio Pharmaceuticals INO Stock Earnings Reports

Q2'26

Est.

$-0.24

Q1'26

Beat

by $0.16

Q4'25

Missed

by $1.14

Q3'25

Beat

by $0.12

Q2'25

Beat

by $0.46

The last earnings report on May 13 showed earnings per share of -28 cents, beating the estimate of -43 cents. With 1.11M shares outstanding, the current market capitalization sits at 90.50M.

View a ticker or compare two or three

Compare

INO

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for INO